TC
BLUE

Tarsadia Capital’s bluebird bio BLUE Stock Holding History

Tarsadia Capital’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-7,720
Closed -$3.2M – 5
2021
Q2 		$3.2M Hold
7,720
– – 0.9% 16
2021
Q1 		$3.02M Buy
7,720
+1,487
+24% +$732K 0.81% 18
2020
Q4 		$3.49M Hold
6,233
– – 0.72% 19
2020
Q3 		$4.36M Hold
6,233
– – 0.36% 20
2020
Q2 		$4.93M Buy
6,233
+1,621
+35% +$1.22M 0.87% 21
2020
Q1 		$2.75M Buy
+4,612
New +$4.49M 0.27% 21

Other funds holding BLUE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

Tarsadia Capital's BLUE Position: Q3 2021 in Review

Tarsadia Capital sold out of bluebird bio (BLUE) in Q3 2021, closing a stake of 7,720 shares — an estimated $3.2M sold.

Tarsadia Capital first reported a position in BLUE in Q1 2020 and held it in 6 quarters. The position peaked at $4.93M in Q2 2020. 196 funds tracked by Wall St. Rank hold BLUE as of Q3 2021.

  • Tarsadia Capital reported no remaining bluebird bio position as of Q3 2021 after selling out during the quarter.
  • Tarsadia Capital sold 7,720 bluebird bio shares in Q3 2021, an estimated $3.2M.
  • Tarsadia Capital first reported a position in bluebird bio in Q1 2020 and held it in 6 quarters.
  • Tarsadia Capital's bluebird bio position peaked at $4.93M in Q2 2020.
  • 196 funds tracked by Wall St. Rank held bluebird bio as of Q3 2021.

Based on Tarsadia Capital's 13F filing for Q3 2021.